Mozambique launches Brazil-funded drugs plant to battle HIV

July 21, 2012

Mozambique on Saturday launched a Brazilian funded pharmaceutical plant that will make anti-retroviral drugs to battle the HIV/AIDS scourge in the southern African country.

The factory -- built with $23 million in aid from Brazil and $4.5 million from that country's mining giant Vale -- will initially package drugs from Brazil but start producing the pills by the end of the year.

Mozambique has more than 2.5 million people living with HIV -- nearly 12 percent of the population -- but fewer than 300,000 of them now take anti-retroviral (ARV) drugs, according to the .

ARVs suppress the , reducing sickness and death rates as well as the transmission of the virus that causes AIDS.

Brazil's Vice President Michel Temer attended Saturday's launch of what is thought to be Africa's first fully public ARV factory in Matola, along with Mozambique's Industry and Commerce Minister Armando Inroga.

"As of now drugs which were manufactured in Brazil will be packaged here in Mozambique, certified and distributed to the Mozambican people," Temer said.

"There is an excellent partnership between the Brazilian and the Mozambican people and there is an absolute integration between the two countries in both public and private sectors."

In 2010 Brazil's then-president Luiz Inacio Lula da Silva visited the plant site and called it a "revolution" in Africa's fight against HIV/AIDS.

Brazil offers free ARV treatment to HIV-positive citizens, a programme that sparked controversy when it was announced in 1996 because of concerns about and violation of pharmaceutical copyright.

But it has since been praised as a model for the developing world. The World Bank estimates the free medicine saved more than half a million lives.

Mozambican technicians and other staff for the plant are now being trained, some of them in Brazil, through a partnership with the Brazilian public health institution A Fundacao Oswaldo Cruz.

Explore further: S.Africa in $208 mln AIDS drug venture with Swiss Lonza

Related Stories

S.Africa in $208 mln AIDS drug venture with Swiss Lonza

February 10, 2012
South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.

South Africa reports new success in saving newborns from HIV

July 19, 2012
About 117,000 babies were saved from HIV infection last year under South Africa's scheme to prevent mothers from passing on the disease during childbirth, health official said Thursday.

Sanofi teams up with India to make cheap ARVs in S.Africa

March 30, 2012
French pharmaceutical giant Sanofi has signed a partnership with India's Hetero to manufacture cheap anti-HIV drugs in South Africa, the company said on Friday.

Recommended for you

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

Researchers find clues to AIDS resistance in sooty mangabey genome

January 3, 2018
Peaceful co-existence, rather than war: that's how sooty mangabeys, a monkey species found in West Africa, handle infection by SIV, a relative of HIV, and avoid developing AIDS-like disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.